Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been roughly seven months since my previous Sarepta Therapeutics ( SRPT ) article titled “Sarepta Therapeutics: Rebuilding the Thesis After Hitting Rock Bottom.” At that time, SRPT was in collapse after ELEVIDYS had become a regulatory nightmare a ...